Genetically engineered drug induces new capillary growth in the ischemic myocardium.
Drown
D J
DJ
Cardiovascular Research Institute, University of California San Francisco 94143-0130, USA.
D002196:Capillaries / Q000187:drug effects / Q000254:growth & development; D003331:Coronary Vessels / Q000187:drug effects* / Q000254:growth & development*; D016220:Fibroblast Growth Factor 1; D016222:Fibroblast Growth Factor 2 / Q000627:therapeutic use*; D005818:Genetic Engineering / Q000379:methods*; D006801:Humans; D017202:Myocardial Ischemia / Q000188:drug therapy*; D018919:Neovascularization, Physiologic / Q000187:drug effects*; D016896:Treatment Outcome
D016222:Fibroblast Growth Factor 2; D016220:Fibroblast Growth Factor 1